It shows a lack of judgment to be buying and selling health care company stocks if you are serving on a congressional committee that is making decisions that are going to impact the value of health care company stocks," ethics expert Richard Painter told CNN. " In particular, if someone has access to confidential information, the (Securities and Exchange Commission) could investigate them. " 